Alere Inc. $425,000,000 6.375% Senior Subordinated Notes due 2023 PURCHASE AGREEMENTPurchase Agreement • June 16th, 2015 • Alere Inc. • In vitro & in vivo diagnostic substances • New York
Introductory. Alere Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers named in Schedule A (the “Initial Purchasers”) $425,000,000 aggregate principal amount of its 6.375% senior subordinated notes due 2023 (the “Notes”). The Company’s obligations under the Notes and the Indenture (as defined below) will be, jointly and severally, unconditionally guaranteed (the “Guarantees”), on a senior subordinated basis, by each of the Subsidiaries (as defined below) listed on the signature pages hereto (collectively, the “Guarantors,” and, together with the Company, the “Issuers”). The Notes and the Guarantees are referred to herein as the “Securities.” The respective principal amounts of the Notes to be so purchased by the several Initial Purchasers are set forth opposite their names in Schedule A hereto. The Notes are to be issued under an indenture dated as of May 12, 2009 (the “Base Indenture”) as supplemented by a supplemental indenture
